Advisory Board

Jan-Olov Sandberg holds a PhD and is an Associate Professor with extensive experience in medical research and the pharmaceutical industry. He is currently Medical Director at Roche AB and has held senior medical positions within the company, including Country Medical Leader Oncology. Jan-Olov has broad experience in oncology and other therapeutic areas, with expertise spanning clinical development, medical affairs, market access, and the translation of scientific and medical innovation into patient care.

Thomas Andersson is Senior Advisor Business Development at Oslo Cancer Cluster Incubator and Oslo Cancer Cluster. Thomas holds a PhD in biophysics from Lund University and has more than 30 years of experience in establishing, operating, and funding start-ups within life sciences. He has extensive experience with biotech investments and operations, having been a member of the senior investment team in the technology transfer office of Karolinska Institute and Karolinska Development. In total, Thomas has been involved in starting more than 20 companies, several of which are noted on the stock market.

Kerstin Jakobsson holds a Master of Science degree from Lund University and brings more than 30 years of experience in international business development, corporate management, and board leadership within the life science sector. She has held several CEO positions, including at Kongsberg Beam Technology AS, SpectraCure AB, Ortoma AB, and Medicon Village Innovation AB, where she successfully led organisations through growth, transformation, and commercialisation phases. Kerstin has completed advanced board training at EFL Executive Education and Board Academy, and she has extensive experience serving on boards of both public and private companies.

Janne Nestvold holds a PhD in Immunology from the Faculty of Medicine at the University of Oslo. Her research experience is from academia and biotech within the field of immuno-oncology. She is currently working as COO at Oslo Cancer Cluster Incubator.